mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.04 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.05 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |